Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
2010 1
2011 3
2012 1
2013 3
2014 1
2015 1
2016 3
2018 3
2019 3
2020 5
2021 9
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
Wray S, Then Bergh F, Wundes A, Arnold DL, Drulovic J, Jasinska E, Bowen JD, Negroski D, Naismith RT, Hunter SF, Gudesblatt M, Chen H, Lyons J, Shankar SL, Kapadia S, Mendoza JP, Singer BA. Wray S, et al. Among authors: mendoza jp. Adv Ther. 2022 Apr;39(4):1810-1831. doi: 10.1007/s12325-022-02068-7. Epub 2022 Feb 24. Adv Ther. 2022. PMID: 35211872 Free PMC article. Clinical Trial.
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies.
Amezcua L, Mao-Draayer Y, Vargas WS, Farber R, Schaefer S, Branco F, England SM, Belviso N, Lewin JB, Mendoza JP, Shankar SL; ENDORSE Study Investigators. Amezcua L, et al. Among authors: mendoza jp. Neurol Ther. 2023 Jun;12(3):883-897. doi: 10.1007/s40120-023-00475-8. Epub 2023 Apr 15. Neurol Ther. 2023. PMID: 37061656 Free PMC article.
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab.
Gudesblatt M, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Li H, Sun Z, Scott N, Mendoza JP, Avila RL. Gudesblatt M, et al. Among authors: mendoza jp. Mult Scler J Exp Transl Clin. 2023 Dec 10;9(4):20552173231218117. doi: 10.1177/20552173231218117. eCollection 2023 Oct-Dec. Mult Scler J Exp Transl Clin. 2023. PMID: 38089563 Free PMC article.
Firms' compliance with complex regulations.
Mendoza JP, Dekker HC, Wielhouwer JL. Mendoza JP, et al. Law Hum Behav. 2016 Dec;40(6):721-733. doi: 10.1037/lhb0000215. Epub 2016 Sep 29. Law Hum Behav. 2016. PMID: 27685641
Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis".
Lager B, Liseno J, Božin I, England SM, Shankar SL, Mendoza JP, Lewin JB. Lager B, et al. Among authors: mendoza jp. Neurol Ther. 2023 Dec;12(6):2199-2203. doi: 10.1007/s40120-023-00536-y. Epub 2023 Sep 14. Neurol Ther. 2023. PMID: 37707704 Free PMC article. No abstract available.
Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.
Longbrake EE, Mao-Draayer Y, Cascione M, Zielinski T, Bame E, Brassat D, Chen C, Kapadia S, Mendoza JP, Miller C, Parks B, Xing D, Robertson D. Longbrake EE, et al. Among authors: mendoza jp. Mult Scler. 2021 May;27(6):883-894. doi: 10.1177/1352458520937282. Epub 2020 Jul 27. Mult Scler. 2021. PMID: 32716690 Free PMC article. Clinical Trial.
38 results